Mirror Tops GPT-5 on Endo Board Exam
💡Curated med AI beats GPT-5 on board exam w/ traceable evidence (87.5% acc)
⚡ 30-Second TL;DR
What Changed
87.5% accuracy (105/120) vs GPT-5.2's 74.6% and humans' 62.3%
Why It Matters
Demonstrates curated evidence layers enable superior subspecialty reasoning over general LLMs with web tools, boosting auditability for clinical use. Highlights potential for specialized AI in medicine beyond broad models.
What To Do Next
Benchmark January Mirror against your LLMs on medical reasoning datasets.
🧠 Deep Insight
Web-grounded analysis with 7 cited sources.
🔑 Enhanced Key Takeaways
- •January Mirror achieved 87.5% accuracy on ESAP 2025 endocrinology board exam, representing a 25.2 percentage point improvement over human endocrinologists (62.3%) and 12.9 points over GPT-5.2 (74.6%)[1]
- •Mirror's architecture uses an ensemble-style clinical reasoning stack with specialized components organized around clinical question archetypes (diagnosis, testing, treatment, prognosis, mechanistic reasoning) and an arbitration layer for final output selection[1]
- •The system demonstrated particular strength on difficult questions where human accuracy fell below 50%, achieving 76.7% accuracy on the 30 hardest questions, suggesting it captures clinical reasoning patterns that challenge subspecialty-trained physicians[1]
- •Mirror operated under closed-evidence constraints without external retrieval, outperforming frontier LLMs (GPT-5, GPT-5.2, Gemini-3-Pro) that had real-time web access to guidelines and primary literature[1]
- •FDA's January 2026 Clinical Decision Support Software guidance shift enables single-recommendation outputs when presented as 'Glass Box' systems with transparent, verifiable reasoning—a regulatory framework that aligns with Mirror's evidence-linked output design[3]
📊 Competitor Analysis▸ Show
| System | Accuracy | Architecture | Evidence Access | Citation Accuracy |
|---|---|---|---|---|
| January Mirror | 87.5% | Ensemble reasoning with arbitration layer | Closed-evidence corpus | 100% verified |
| GPT-5.2 | 74.6% | General-purpose LLM | Real-time web access | Not specified |
| GPT-5 | ~70-72% (inferred) | General-purpose LLM | Real-time web access | Not specified |
| Gemini-3-Pro | ~70-72% (inferred) | General-purpose LLM | Real-time web access | Not specified |
| Human endocrinologists (reference) | 62.3% | Clinical expertise | Domain knowledge | N/A |
🛠️ Technical Deep Dive
• Reasoning Architecture: Ensemble-style clinical reasoning stack with multiple specialized reasoning components generating candidate answers and supporting evidence links, followed by arbitration layer using evidence quality and internal agreement signals • Question Archetype Organization: Components structured around common clinical reasoning tasks—diagnosis, testing, treatment, prognosis, and mechanistic reasoning—reflecting how clinicians approach distinct problem types • Evidence Integration: System integrates curated endocrinology and cardiometabolic evidence corpus with structured reasoning architecture to generate evidence-linked outputs; operates under closed-evidence constraint without external retrieval • Output Design: Outputs include traceable citations from guidelines with 100% citation accuracy verification; 74.2% of outputs cited guideline sources • Performance Metrics: Top-2 accuracy of 92.5% vs GPT-5.2's 85.25%, indicating strong confidence in alternative diagnoses • Regulatory Alignment: Design aligns with FDA's January 2026 'Glass Box' CDS guidance requiring transparent, clinician-reviewable logic and verifiable source grounding rather than hallucinated citations[3]
🔮 Future ImplicationsAI analysis grounded in cited sources
Mirror's performance demonstrates that domain-specific evidence curation and structured clinical reasoning can achieve subspecialty-level performance exceeding general-purpose frontier LLMs, suggesting a strategic shift toward specialized clinical AI systems rather than relying on general-purpose models with web access. The January 2026 FDA guidance shift toward 'Glass Box' transparency requirements creates regulatory tailwinds for evidence-grounded systems like Mirror while restricting black-box approaches. This validates a design philosophy where AI augments rather than replaces clinician judgment through transparent reasoning. The closed-evidence advantage over web-enabled LLMs indicates that curated, high-quality evidence corpora may outperform real-time information access in specialized domains. Healthcare organizations may increasingly adopt domain-specific clinical reasoning systems for subspecialty applications, particularly in high-stakes diagnostic and treatment planning contexts where explainability and citation accuracy are regulatory and clinical requirements. The framework's success on difficult questions suggests potential for AI-assisted continuing medical education and quality improvement in areas where even subspecialty physicians struggle.
⏳ Timeline
📎 Sources (7)
Factual claims are grounded in the sources below. Forward-looking analysis is AI-generated interpretation.
Weekly AI Recap
Read this week's curated digest of top AI events →
👉Related Updates
AI-curated news aggregator. All content rights belong to original publishers.
Original source: ArXiv AI ↗